Industrial Contracts Office
1705 El Camino Real
Palo Alto, CA 94306
Material Transfer Agreements (MTAs)
MTAs are contracts governing the transfer of tangible research property for pre-clinical research use.
MTAs may be used in the following instances:
Incoming MTAs govern the transfer of material from another entity to Stanford. All MTAs to the University must be reviewed and signed by ICO. If you are interested in sending material to a researcher at Stanford, please contact ICO at email@example.com.
Outgoing MTAs govern the transfer of materials from Stanford to researchers outside the University. Stanford encourages researchers to share their materials with colleagues without an MTA when possible. But MTA's are required for transfers of human tissues and CIRM-funded materials. If the Stanford researcher wants to use an MTA to send materials, the template below may be used.
Human Tissue Transfers
Stanford requires Human Tissue Transfer Agreements when human research specimens are transferred outside of Stanford. These transfers must be approved by the University's Human Subjects Panels (IRB).
The California Institute for Regenerative Medicine (CIRM) requires an MTA to transfer research materials created using CIRM funds, and these transfers are reported to CIRM.
Human Stem Cells and Human Embryos
Research involving human adult, fetal, or embryonic stem cells or human embryos requires compliance with special state and federal regulations. All human stem cell research projects must be reviewed and approved by Stanford’s Stem Cell Research Oversight Committee (SCRO). If you are interested in sending or receiving human stem cells or human embryos to a researcher at Stanford, please contact ICO at firstname.lastname@example.org.
Master MTAs govern the ongoing transfer of material between Stanford and other organizations. The Master MTA terms and conditions remain the same for each material transferred. The specifics of each transfer are documented in an Exhibit to the Master. Stanford has Master MTAs in place with Biogen, StemCells, Inc., Rigel Pharmaceuticals, Inc., Genentech, and Kosan Biosciences.
Please feel free to call us at 650-723-0651 or email us at email@example.com.